idazoxan extended release (TR-01)
/ Terran Biosci
- LARVOL DELTA
Home
Next
Prev
1 to 5
Of
5
Go to page
1
March 18, 2026
A Study of Idazoxan in Healthy Participants
(clinicaltrials.gov)
- P1 | N=150 | Active, not recruiting | Sponsor: Terran Biosciences Australia Pty Ltd | Recruiting ➔ Active, not recruiting | Trial completion date: Mar 2024 ➔ Dec 2027 | Trial primary completion date: Mar 2024 ➔ Dec 2027
Enrollment closed • Trial completion date • Trial primary completion date
January 01, 2024
A Study of Idazoxan in Healthy Participants
(clinicaltrials.gov)
- P1 | N=150 | Recruiting | Sponsor: Terran Biosciences Australia Pty Ltd
Trial completion date • Trial primary completion date
November 27, 2023
A Study of Idazoxan in Healthy Participants
(clinicaltrials.gov)
- P1 | N=150 | Recruiting | Sponsor: Terran Biosciences Australia Pty Ltd | N=110 ➔ 150
Enrollment change
March 01, 2023
A Study of Idazoxan in Healthy Participants
(clinicaltrials.gov)
- P1 | N=110 | Recruiting | Sponsor: Terran Biosciences Australia Pty Ltd | Not yet recruiting ➔ Recruiting
Enrollment open
February 14, 2023
A Study of the Safety, Tolerability and Pharmacokinetics of Idazoxan in Healthy Participants
(clinicaltrials.gov)
- P1 | N=110 | Not yet recruiting | Sponsor: Terran Biosciences Australia Pty Ltd
New P1 trial
1 to 5
Of
5
Go to page
1